Literature DB >> 2683154

A prospective evaluation of the Port-A-Cath implantable venous access system in chronically ill adults and children.

W H Harvey1, T E Pick, K Reed, R I Solenberger.   

Abstract

Totally implantable venous access systems are presently widely used, but large-scale, prolonged studies are lacking in evaluating adequately these systems. We prospectively evaluated 198 systems in 191 patients (ages from two months to 80 years) during a three year period, with a median follow-up time of 330 days (a range of two to 1,088 days). Withdrawal of blood was consistently successful in 91 per cent of the systems. Complication rates for infection and thrombosis were 0.04 and 0.03 per 100 days of catheterization, respectively. No episodes of migration of the catheter or embolization were noted. This was thought to be the result of the placement of all catheters by a cutdown technique rather than percutaneously. Five systems were removed because of thrombosis and 22, because of infection. Implantable venous access devices are reliable and have a low complication rate in adult and pediatric patients who require repetitive venous access.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2683154

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  9 in total

1.  [Complications of venous port systems : Radiological diagnostics and minimally invasive therapy].

Authors:  N Rathmann; D Hausmann; M Kostrzewa; M Keese; S Diehl; S Schönberg; M Sadick
Journal:  Radiologe       Date:  2011-05       Impact factor: 0.635

2.  [The clinical and pharmacokinetic results of intrapleural epirubicin application].

Authors:  R B Schilcher; A N Rahn; M E Scheulen
Journal:  Strahlenther Onkol       Date:  1997-04       Impact factor: 3.621

3.  Long-term antimicrobial treatment of severe infections using a fully implantable catheter system.

Authors:  J Fabbri; U Laffer; W Zimmerli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-04       Impact factor: 3.267

4.  Clinical and microbiological characteristics of Flavobacterium indologenes infections associated with indwelling devices.

Authors:  P R Hsueh; L J Teng; S W Ho; W C Hsieh; K T Luh
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

5.  Analysis of risk factors for central venous port failure in cancer patients.

Authors:  Ching-Chuan Hsieh; Hsu-Huei Weng; Wen-Shih Huang; Wen-Ke Wang; Chiung-Lun Kao; Ming-Shian Lu; Chia-Siu Wang
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

6.  Safety of a totally implantable central venous port system with percutaneous subclavian vein access.

Authors:  Dong-Yoon Keum; Jae-Bum Kim; Min-Cheol Chae
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2013-06-05

7.  Case of recurrent Flavimonas oryzihabitans bacteremia associated with an implanted central venous catheter (Port-A-Cath): assessment of clonality by arbitrarily primed PCR.

Authors:  B Verhasselt; G Claeys; A Elaichouni; G Verschraegen; G Laureys; M Vaneechoutte
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

8.  Liver regional continuous chemotherapy: use of femoral or subclavian artery for percutaneous implantation of catheter-port systems.

Authors:  An-Long Zhu; Lian-Xin Liu; Da-Xun Piao; Ya-Xin Lin; Jin-Peng Zhao; Hong-Chi Jiang
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

9.  Implantable Venous Access Devices in Pediatric Malignancies - Institutional Experience in a Developing Nation.

Authors:  Jegadeesh Sundaram; Prakash Agarwal; Madhu Ramasundaram; Selvapriya Barathi
Journal:  J Indian Assoc Pediatr Surg       Date:  2020-09-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.